These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36750933)

  • 21. EIF5A2 Is Involved in the Biological Process of Cervical Cancer Cells through AGR2.
    Shen X; Li L; He Y; Lv X; Ma J
    Pharmacology; 2022; 107(7-8):376-385. PubMed ID: 35640539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma.
    Tang DJ; Dong SS; Ma NF; Xie D; Chen L; Fu L; Lau SH; Li Y; Li Y; Guan XY
    Hepatology; 2010 Apr; 51(4):1255-63. PubMed ID: 20112425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implications of the Use of Eukaryotic Translation Initiation Factor 5A (eIF5A) for Prognosis and Treatment of Hepatocellular Carcinoma.
    Shek FH; Fatima S; Lee NP
    Int J Hepatol; 2012; 2012():760928. PubMed ID: 23029619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of eukaryotic translation initiation factor 5A2 enhances the therapeutic efficiency of doxorubicin in hepatocellular carcinoma cells by triggering lethal autophagy.
    Tang Y; Chen K; Luan X; Zhang J; Liu R; Zheng X; Xie S; Ke H; Zhang X; Chen W
    Int J Oncol; 2020 Dec; 57(6):1368-1380. PubMed ID: 33174013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia reduces ER-to-Golgi protein trafficking and increases cell death by inhibiting the adaptive unfolded protein response in mouse beta cells.
    Bensellam M; Maxwell EL; Chan JY; Luzuriaga J; West PK; Jonas JC; Gunton JE; Laybutt DR
    Diabetologia; 2016 Jul; 59(7):1492-1502. PubMed ID: 27039902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition.
    Zhu W; Cai MY; Tong ZT; Dong SS; Mai SJ; Liao YJ; Bian XW; Lin MC; Kung HF; Zeng YX; Guan XY; Xie D
    Gut; 2012 Apr; 61(4):562-75. PubMed ID: 21813470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human eIF5A2 on chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expression.
    Jenkins ZA; Hååg PG; Johansson HE
    Genomics; 2001 Jan; 71(1):101-9. PubMed ID: 11161802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eukaryotic translation initiation factor 5A and its posttranslational modifications play an important role in proliferation and potentially in differentiation of the human enteric protozoan parasite Entamoeba histolytica.
    Jeelani G; Nozaki T
    PLoS Pathog; 2021 Feb; 17(2):e1008909. PubMed ID: 33592076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo.
    Wei JH; Cao JZ; Zhang D; Liao B; Zhong WM; Lu J; Zhao HW; Zhang JX; Tong ZT; Fan S; Liang CZ; Liao YB; Pang J; Wu RH; Fang Y; Chen ZH; Li B; Xie D; Chen W; Luo JH
    Br J Cancer; 2014 Apr; 110(7):1767-77. PubMed ID: 24504366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eukaryotic translation initiation factor 5A2 regulates the migration and invasion of hepatocellular carcinoma cells via pathways involving reactive oxygen species.
    Liu RR; Lv YS; Tang YX; Wang YF; Chen XL; Zheng XX; Xie SZ; Cai Y; Yu J; Zhang XN
    Oncotarget; 2016 Apr; 7(17):24348-60. PubMed ID: 27028999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of eukaryotic initiation factor 5A2 in human cancer.
    Wang FW; Guan XY; Xie D
    Int J Biol Sci; 2013; 9(10):1013-20. PubMed ID: 24250246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ablation of EIF5A2 induces tumor vasculature remodeling and improves tumor response to chemotherapy via regulation of matrix metalloproteinase 2 expression.
    Wang FW; Cai MY; Mai SJ; Chen JW; Bai HY; Li Y; Liao YJ; Li CP; Tian XP; Kung HF; Guan XY; Xie D
    Oncotarget; 2014 Aug; 5(16):6716-33. PubMed ID: 25071013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions Between
    Wang S; Cheng M; Zheng X; Zheng L; Liu H; Lu J; Liu Y; Chen W
    Onco Targets Ther; 2020; 13():13159-13170. PubMed ID: 33380806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-588 regulates invasion, migration and epithelial-mesenchymal transition via targeting EIF5A2 pathway in gastric cancer.
    Zhou X; Xu M; Guo Y; Ye L; Long L; Wang H; Tan P; Xu M
    Cancer Manag Res; 2018; 10():5187-5197. PubMed ID: 30464616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulated expression of the antioxidant sestrin 2 identified by transcriptomic analysis of Japanese encephalitis virus-infected SH-SY5Y neuroblastoma cells.
    Carr M; Gonzalez G; Martinelli A; Wastika CE; Ito K; Orba Y; Sasaki M; Hall WW; Sawa H
    Virus Genes; 2019 Oct; 55(5):630-642. PubMed ID: 31292858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting eIF5A2 inhibits prostate carcinogenesis, migration, invasion and metastasis
    Zhong X; Xiu H; Bi Y; Zhang H; Chang L; Diao H
    Bioengineered; 2020 Jan; 11(1):619-627. PubMed ID: 32522053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgen receptor regulates eIF5A2 expression and promotes prostate cancer metastasis via EMT.
    Zheng Y; Li P; Huang H; Ye X; Chen W; Xu G; Zhang F
    Cell Death Discov; 2021 Dec; 7(1):373. PubMed ID: 34864817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thermo-chemotherapy inhibits the proliferation and metastasis of gastric cancer cells via suppression of EIF5A2 expression.
    Ba MC; Ba Z; Cui SZ; Gong YF; Chen C; Lin KP; Wu YB; Tu YN
    Onco Targets Ther; 2019; 12():6275-6284. PubMed ID: 31496731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
    Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
    Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eukaryotic initiation factor 5A2 mediates hypoxia-induced autophagy and cisplatin resistance.
    Xu G; Chen H; Wu S; Chen J; Zhang S; Shao G; Sun L; Mu Y; Liu K; Pan Q; Li N; An X; Lin S; Chen W
    Cell Death Dis; 2022 Aug; 13(8):683. PubMed ID: 35931669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.